Autopsy report · NCT00300495

Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection

“Unable to accrual total number of participants during study period.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years 8 months before it stopped.
• 19 participants enrolled.
• Results were posted on the registry 7 years 6 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Beth Israel Deaconess Medical Center

Sponsor type

University, hospital or other

Conditions

Atrial Fibrillation; Lung Cancer

Interventions

Amiodarone; Control arm, standard care

Participants

19

Sites

1

Countries

United States

Trials that died the same way

• Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma
  “The study was unable the accrue the required number of patients within a reasonable time.” (73% match in meaning)
• Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)
  “Study was unable to accrue subjects” (70% match in meaning)
• Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
  “Accrual was insufficient to meet study endpoints” (69% match in meaning)
• Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent
  “Study stopped due to lack of accrual” (67% match in meaning)
• Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
  “Study was halted for lack of accrual” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.